Результати пошуку - J-T Sun
- Показ 1 - 9 результатів із 9
-
1
Pestalotioid Species Associated with Medicinal Plants in Southwest China and Thailand за авторством YR Sun, Ruvishika S. Jayawardena, J. E. Sun, Yong Wang
Опубліковано 2023Artigo -
2
The prevalence of migraine in university students: a systematic review and meta‐analysis за авторством Xin Wang, Haojing Zhou, J. M. Sun, Yun Xing, Yaxin Zhu, Yashuang Zhao
Опубліковано 2015Revisão -
3
-
4
Small-cell lung cancer detection in never-smokers: clinical characteristics and multigene mutation profiling using targeted next-generation sequencing за авторством J-M Sun, Y-L Choi, Jun Ho Ji, Jin Seok Ahn, K-M Kim, Jingjing Han, M-J Ahn, K. Park
Опубліковано 2014Artigo -
5
Virtual Reality Exposure to a Healthy Weight Body Is a Promising Adjunct Treatment for Anorexia Nervosa за авторством Simone C. Behrens, Joachim Tesch, Philine J.B. Sun, Sebastian Starke, Michael J. Black, Hannah Schneider, Jacopo Pruccoli, Stephan Zipfel, Katrin Elisabeth Giel
Опубліковано 2023Artigo -
6
CD16+ monocytes in breast cancer patients: expanded by monocyte chemoattractant protein-1 and may be useful for early diagnosis за авторством A-L Feng, J-K Zhu, J-T Sun, M-X Yang, Markus Neckenig, Xiuwen Wang, Q-Q Shao, B-F Song, Qifeng Yang, B-H Kong, Xiujuan Qu
Опубліковано 2011Artigo -
7
POLE Mutation Spectra Are Shaped by the Mutant Allele Identity, Its Abundance, and Mismatch Repair Status за авторством Karl P. Hodel, Meijuan J.S. Sun, Nathan Ungerleider, Vivian S. Park, Leonard G. Williams, David L. Bauer, Victoria E. Immethun, Jieqiong Wang, Zucai Suo, Hua Lu, James B. McLachlan, Zachary F. Pursell
Опубліковано 2020Artigo -
8
Breast cancer cells survive chemotherapy by activating targetable immune-modulatory programs characterized by PD-L1 or CD80 за авторством Ashkan Shahbandi, Fang-Yen Chiu, Nathan Ungerleider, Raegan Kvadas, Zeinab Mheidly, Meijuan J.S. Sun, Di Tian, Daniel A. Waizman, Ashlyn Y. Anderson, Heather L. Machado, Zachary F. Pursell, Sonia G. Rao, James G. Jackson
Опубліковано 2022Artigo -
9
LBA8_PR Pembrolizumab plus chemotherapy versus chemotherapy as first-line therapy in patients with advanced esophageal cancer: The phase 3 KEYNOTE-590 study за авторством Ken Kato, J-M. Sun, Manan Shah, Peter C. Enzinger, Antoine Adenis, Toshihiko Doi, Takashi Kojima, J-P. Metges, Zhouxiao Li, S-B Kim, B.C. Chul Cho, Wasat Mansoor, SH Li, Patrapim Sunpaweravong, María Maqueda, Eray Goekkurt, Q. Liu, Sukrut Shah, Pooja Bhagia, Lin Shen
Опубліковано 2020Artigo